On the public citation graph

Development and Characterisation of Antibody-Based Optical Imaging Probes for Inflammatory Bowel Disease

0 signed · 44 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/s00535-018-1449-zopenalex-snapshot
New treatment options for inflammatory bowel diseases
inferredcites →https://doi.org/10.1007/s40262-017-0546-0openalex-snapshot
A Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Vedolizumab
inferredcites →https://doi.org/10.1016/j.dld.2018.06.009openalex-snapshot
Molecular imaging in gastroenterology: A route for personalized endoscopy
inferredcites →https://doi.org/10.1016/j.gie.2017.01.012openalex-snapshot
Molecular imaging of mucosal α4β7 integrin expression with the fluorescent anti-adhesion antibody vedolizumab in Crohn’s disease
inferredcites →https://doi.org/10.1016/s0140-6736(12)60026-9openalex-snapshot
Crohn's disease
inferredcites →https://doi.org/10.1016/s2468-1253(16)30082-6openalex-snapshot
Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study
inferredcites →https://doi.org/10.1016/s2468-1253(20)30088-1openalex-snapshot
Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre, open-label, single-arm, dose-escalation study
inferredcites →https://doi.org/10.1038/ajg.2011.103openalex-snapshot
Assessing Response and Loss of Response to Biological Therapies in IBD
inferredcites →https://doi.org/10.1038/ajg.2018.27openalex-snapshot
ACG Clinical Guideline: Management of Crohn's Disease in Adults
inferredcites →https://doi.org/10.1038/nm.2472openalex-snapshot
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
inferredcites →https://doi.org/10.1038/nm.3462openalex-snapshot
In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease
inferredcites →https://doi.org/10.1038/nrgastro.2015.135openalex-snapshot
Biologic agents for IBD: practical insights
inferredcites →https://doi.org/10.1038/nrgastro.2015.150openalex-snapshot
The global burden of IBD: from 2015 to 2025
inferredcites →https://doi.org/10.1038/s41467-019-11014-1openalex-snapshot
A zwitterionic near-infrared fluorophore for real-time ureter identification during laparoscopic abdominopelvic surgery
inferredcites →https://doi.org/10.1038/s41598-021-84831-4openalex-snapshot
Molecular imaging of a fluorescent antibody against epidermal growth factor receptor detects high-grade glioma
inferredcites →https://doi.org/10.1053/j.gastro.2016.10.036openalex-snapshot
Etiology and Treatment of Pain and Psychosocial Issues in Patients With Inflammatory Bowel Diseases
inferredcites →https://doi.org/10.1053/j.gastro.2016.12.009openalex-snapshot
Detection of Sessile Serrated Adenomas in the Proximal Colon Using Wide-Field Fluorescence Endoscopy
inferredcites →https://doi.org/10.1056/nejmra1102942openalex-snapshot
Ulcerative Colitis
inferredcites →https://doi.org/10.1093/ibd/izy171openalex-snapshot
Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease
inferredcites →https://doi.org/10.1111/apt.14550openalex-snapshot
Review article: predictors of response to vedolizumab and ustekinumab in inflammatory bowel disease
inferredcites →https://doi.org/10.1111/jgh.14584openalex-snapshot
Immunogenicity is not the driving force of treatment failure in vedolizumab‐treated inflammatory bowel disease patients
inferredcites →https://doi.org/10.1136/gutjnl-2017-314953openalex-snapshot
Near-infrared fluorescence molecular endoscopy detects dysplastic oesophageal lesions using topical and systemic tracer of vascular endothelial growth factor A
inferredcites →https://doi.org/10.1136/gutjnl-2018-316023openalex-snapshot
Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease
inferredcites →https://doi.org/10.1136/gutjnl-2019-319755openalex-snapshot
Quantitative fluorescence endoscopy: an innovative endoscopy approach to evaluate neoadjuvant treatment response in locally advanced rectal cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-14-3284openalex-snapshot
Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer
inferredcites →https://doi.org/10.1159/000437062openalex-snapshot
Molecular Endoscopy and in vivo Imaging in Inflammatory Bowel Diseases
inferredcites →https://doi.org/10.1159/000445262openalex-snapshot
Predicting Therapeutic Response by in vivo Molecular Imaging in Inflammatory Bowel Diseases
inferredcites →https://doi.org/10.1245/s10434-018-6655-7openalex-snapshot
Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent
inferredcites →https://doi.org/10.14309/ajg.0000000000000152openalex-snapshot
ACG Clinical Guideline: Ulcerative Colitis in Adults
inferredcites →https://doi.org/10.2147/jir.s165330openalex-snapshot
Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives
inferredcites →https://doi.org/10.2967/jnumed.118.216556openalex-snapshot
Roadmap for the Development and Clinical Translation of Optical Tracers Cetuximab-800CW and Trastuzumab-800CW
inferredcites →https://doi.org/10.3389/fimmu.2017.01256openalex-snapshot
Imaging of Mucosal Inflammation: Current Technological Developments, Clinical Implications, and Future Perspectives
inferredcites →https://doi.org/10.3748/wjg.v22.i3.1246openalex-snapshot
Advanced gastrointestinal endoscopic imaging for inflammatory bowel diseases

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4796026openalex-extracted
Endoscopic Fluorescence Imaging Spectroscopy for Highly-Sensitive and High-Fidelity Diagnosis of Gastrointestinal Cancer in Vivo
inferred← citeshttps://doi.org/10.1002/adhm.202202420openalex-snapshot
Orally Administrable Aggregation‐Induced Emission‐Based Bionic Probe for Imaging and Ameliorating Dextran Sulfate Sodium‐Induced Inflammatory Bowel Diseases
inferred← citeshttps://doi.org/10.1016/j.ijpx.2026.100514openalex-snapshot
Roadmap for the accelerated development and clinical translation of fluorescent tracers: Adalimumab-680LT as a proof of concept
inferred← citeshttps://doi.org/10.1080/19420862.2026.2743444openalex-snapshot
Tangential flow filtration as a novel approach for fluorescent tracer purification and production up-scaling: cetuximab-800CW and ustekinumab-800CW as a proof-of-concept
inferred← citeshttps://doi.org/10.1101/2023.10.25.23297524openalex-snapshot
Using fluorescently labeled vedolizumab to visualize local drug distribution during colonoscopy and identify mucosal target cells in patients with inflammatory bowel disease
inferred← citeshttps://doi.org/10.1136/gutjnl-2023-331696openalex-snapshot
Fluorescently labelled vedolizumab to visualise drug distribution and mucosal target cells in inflammatory bowel disease
inferred← citeshttps://doi.org/10.1155/2022/9589820openalex-snapshot
Near-Infrared Fluorescence Imaging of EGFR-Overexpressing Tumors in the Mouse Xenograft Model Using scFv-IRDye800CW and Cetuximab-IRDye800CW
inferred← citeshttps://doi.org/10.3390/diagnostics13091591openalex-snapshot
Detection of Tumour-Targeted IRDye800CW Tracer with Commercially Available Laparoscopic Surgical Systems
inferred← citeshttps://doi.org/10.3390/ph18101501openalex-snapshot
Development of Clinical-Grade Durvalumab-680LT and Nivolumab-800CW for Multispectral Fluorescent Imaging of the PD-1/PD-L1 Axis of the Immune Checkpoint Pathway
inferred← citeshttps://doi.org/10.3390/pharmaceutics17010074openalex-snapshot
Development of an Adaptable Qualification Test Set for Personnel Involved in Visual Inspection Procedures of Parenteral Drug Products Manufactured Under Good Manufacturing Practice Conditions in Hospital Pharmacy Compounding Facilities
inferred← citeshttps://doi.org/10.46879/ukroj.3.2024.333-344openalex-snapshot
Point-of-care ultrasound of the inflammatory bowel disease
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.